Michael A. Zasloff's most recent trade in Amphastar Pharmaceuticals Inc was a trade of 11,402 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 11,402 | 11,402 | - | - | Stock Option (right to buy) | |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 5,122 | 29,524 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 6,864 | 6,864 | - | - | Stock Option (right to buy) | |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 3,076 | 24,402 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Sale of securities on an exchange or to another person at price $ 47.06 per share. | 05 Mar 2024 | 9,389 | 24,437 (0%) | 0% | 47.1 | 441,871 | Common Stock |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Sale of securities on an exchange or to another person at price $ 47.53 per share. | 05 Mar 2024 | 3,111 | 21,326 (0%) | 0% | 47.5 | 147,853 | Common Stock |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Sale of securities on an exchange or to another person at price $ 57.22 per share. | 15 Aug 2023 | 12,759 | 33,826 (0%) | 0% | 57.2 | 730,025 | Common Stock |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 7,016 | 7,016 | - | - | Stock Option (right to buy) | |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 2,716 | 46,585 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Sale of securities on an exchange or to another person at price $ 42.18 per share. | 15 May 2023 | 7,500 | 43,869 (0%) | 0% | 42.2 | 316,335 | Common Stock |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 10,984 | 10,984 | - | - | Stock Option (right to buy) | |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 4,163 | 51,369 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Sale of securities on an exchange or to another person at price $ 35.61 per share. | 16 May 2022 | 10,291 | 47,206 (0%) | 0% | 35.6 | 366,500 | Common Stock |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.11 per share. | 16 May 2022 | 10,291 | 57,497 (0%) | 0% | 17.1 | 176,079 | Common Stock |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2022 | 10,291 | 0 | - | - | Stock Option (right to buy) | |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 10,000 | 10,291 | - | - | Stock Option (right to buy) | |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.11 per share. | 16 Mar 2022 | 10,000 | 57,206 (0%) | 0% | 17.1 | 171,100 | Common Stock |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Sale of securities on an exchange or to another person at price $ 33.71 per share. | 16 Mar 2022 | 10,000 | 47,206 (0%) | 0% | 33.7 | 337,069 | Common Stock |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 17,182 | 17,182 | - | - | Stock Option (right to buy) | |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 6,019 | 47,206 (0%) | 0% | 0 | Common Stock | |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Sale of securities on an exchange or to another person at price $ 19.34 per share. | 13 May 2021 | 25,827 | 41,187 (0%) | 0% | 19.3 | 499,435 | Common Stock |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 May 2021 | 25,827 | 0 | - | - | Stock Option (right to buy) | |
| Amphastar Pharma Inc | Michael A. Zasloff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.43 per share. | 13 May 2021 | 25,827 | 67,014 (0%) | 0% | 16.4 | 424,338 | Common Stock |